Expert nurse practitioners discuss evidence-based recommendations for how best to incorporate new therapeutic options for patients with advanced urothelial cancer.
NPs and PAs in oncology
This activity is supported by an educational grant from Astellas & Seagen Inc.
Cristina Salabao, MSN, FNP-C, AOCNP, has no relevant financial relationships to disclose.
Mary Weinstein Dunn, MSN, NP-C, OCN, RN, has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 104922O-CT2